Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study with GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2000
Report date:
2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes
Remarks:
BASF AG, Experimental Toxicology and Ecology
Type of assay:
bacterial reverse mutation assay

Test material

Reference
Name:
Unnamed
Type:
Constituent
Details on test material:
- Name of test material (as cited in study report): 520 F-Chlormethyloximether (Stufe 9 der BAS 520 FSynthese)
- Physical state: crystalline / grey
- Analytical purity: 98.3 g/100 g
- Lot/batch No.: 29388-136
- Storage condition of test material: room temperature

Method

Target gene:
histidine and tryptophan auxotrophy
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
Aroclor 1254 induced rat liver S-9 mix
Test concentrations with justification for top dose:
1st experiment, Standard plate test (with and without metabolic activation): 0, 20, 100, 500, 2500 and 5000 µg/plate
2nd experiment, Standard plate test (with and without metabolic activation): 0, 1000, 2000, 4000, 6000 and 8000 µg/plate
3rd experiment, Preincubation test (with and without metabolic activation): 0, 20, 100, 500, 2500 and 5000 µg/plate

Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Due to the insolubility of the test substance in water, DMSO was selected as the vehicle, which had been demonstrated to be suitable in bacterial reverse mutation tests and for which historical control data are available.
Controlsopen allclose all
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: 2-aminoanthracene (2-AA), 2.5-60 µg/ml for all strains
Remarks:
with S9 mix
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: N-methyl-N-nitro-N-nitrosoguanidine (MNNG), 5 µg/plate for TA1535 and TA100
Remarks:
without S9 mix
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: 4-nitro-o-phenylendiamine (NOPD), 10 µg/plate for TA98
Remarks:
without S9 mix
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
9-aminoacridine
Remarks:
without S9 mix

Migrated to IUCLID6: 100 µg/plate for TA1537
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
Remarks:
without S9 mix

Migrated to IUCLID6: 5 µg/ml for E. coli WP2 uvrA
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation


DURATION
The experimental procedure of the Standard Plate Test (plate incorporation method) was based on the method of Ames et al (Mut. Res., 31 347 -364, 1975). The experimental procedure of the Preincubation Test was based on the method described by Yahagi et al. (Mut. Res., 48 121 - 130, 1977) and Matsushima et al. (In: Norpoth, K.H. and R.C. Garner, Short-Term Test Systems for Detecting Carcinogens. Springer Verlag Berlin, Heidelberg, New York, 1980).


NUMBER OF REPLICATIONS: 3

Evaluation criteria:
- The test chemical is considered positive in this assay if a dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strains either without S-9 mix or after adding a metabolizing system.
- A test substance is generally considered non-mutagenic in this test if the number of revertants for all tester strains were within the historical negative control range under all experimental conditions in two experiments carried out independently of each other.

Results and discussion

Test resultsopen allclose all
Species / strain:
other: S. typhimurium TA 1535, TA 1537, TA 98, TA 100, and E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
from 500 µg/plate onwards in the preincubation assay
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Species / strain:
other: S. typhimurium TA 1535, TA 1537, TA 98, TA 100, and E. coli WP2 uvr A
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 8000 µg/plate only using TA 100 in the standard plate test
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No test substance precipitation was found


RANGE-FINDING/SCREENING STUDIES: Dose selection used in repeat studies or further experiments were based an the findings of the 1st experiment.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Expt. 1: Standard plate test: Mean Revertants/ plate (±SE)

Dose (µg/plate)

        TA 98

       TA 100

      TA 1535

      TA 1537

      WP2uvrA

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

0

30±4

41±6

141±9

147±3

17±1

21±2

11±2

9±2

27±4

33±3

20

24±7

32±2

141±12

151±10

20±5

20±4

8±2

9±1

28±7

29±6

100

23±3

33±7

146±14

173±37

22±2

23±4

8±3

13±1

28±3

39±2

500

24±4

26±5

139±11

154±8

28±3

19±2

10±3

11±2

29±4

34±2

2500

25±5

26±6

185±9

172±18

25±5

23±4

10±3

6±3

26±4

28±3

5000

18±2

24±3

181±15

187±28

22±4

16±4

9±3

6±2

28±7

24±3

PC

984±58

969±69

641±48

1333±133

621±20

174±16

722±101

114±16

888±44

215±10

Expt. 2: Standard plate test: Mean Revertants/ plate (±SE)

Dose (µg/plate)

       TA 100

-S9

+S9

0

118±14

133±9

1000

134±16

144±17

2000

176±12

144±13

4000

126±15

168±21

6000

112±17

138±7

8000

79±20

91±3

PC

729±114

1480±70

Expt. 3: Pre-incubation test: Mean Revertants/ plate (±SE)

Dose (µg/plate)

        TA 98

       TA 100

      TA 1535

      TA 1537

      WP2uvrA

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

0

34±3

28±3

124±5

117±9

18±1

18±4

9±3

12±2

23±3

27±2

20

29±4

32±3

105±11

114±15

19±3

21±4

9±2

12±3

21±7

24±5

100

26±2

27±3

119±10

102±10

20±1

17±1

10±1

9±3

19±2

23±3

500

27±6

24±4

92±5

78±3

21±5

13±2

9±1

10±2

22±3

17±5

2500

26±2

26±4

108±4

99±8

22±4

15±4

7±3

7±1

20±3

15±2

5000

19±2

23±2

84±1

110±5

19±2

13±1

6±2

6±1

14±5

17±4

PC

894±94

1023±70

1626±55

649±43

1310±112

114±10

704±21

118±20

699±83

208±17

An increase in the number of his+ or trp+ revertants was not observed both in the standard plate test and in the pre-incubation test either without S-9 mix or after the addition of a metabolizing system. According to the results of the present study, the test substance 520 F-Chlormethyloximether (Stufe 9 der BAS 520 F-Synthese) is not mutagenic in the Salmonella typhimurium/ Escherichia coli reverse mutation assay under the experimental conditions chosen here.

Applicant's summary and conclusion